Your browser doesn't support javascript.
loading
Ceftriaxone Versus Cefazolin Susceptibility as a Surrogate Marker for Cefpodoxime Susceptibility in Enterobacterales.
Lambert, Kaitlyn V; Demkowicz, Ryan; Murray, Amanda; Howard, Catessa; Slain, Douglas.
Affiliation
  • Lambert KV; Department of Pharmacy Services, WVU Medicine, Morgantown, West Virginia, USA.
  • Demkowicz R; Department of Microbiology, WVU Medicine, Morgantown, West Virginia, USA.
  • Murray A; Department of Microbiology, WVU Medicine, Morgantown, West Virginia, USA.
  • Howard C; Department of Pharmacy Services, WVU Medicine, Morgantown, West Virginia, USA.
  • Slain D; Department of Clinical Pharmacy, Department of Medicine, West Virginia University, Morgantown, West Virginia, USA.
Open Forum Infect Dis ; 11(7): ofae377, 2024 Jul.
Article in En | MEDLINE | ID: mdl-39006314
ABSTRACT
The Clinical and Laboratory Standards Institute stated that cefpodoxime susceptibility among Enterobacterales can be inferred from cefazolin, but this may overcall cefpodoxime resistance. We report a categorical agreement rate of 64% for cefazolin and 97% for ceftriaxone with cefpodoxime (P = .0001). Ceftriaxone appears to be a more useful cefpodoxime surrogate.
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Open Forum Infect Dis Year: 2024 Document type: Article Affiliation country: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Open Forum Infect Dis Year: 2024 Document type: Article Affiliation country: Estados Unidos